Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world and the third most common cause of cancer mortality1. Despite the high numbers of patients diagnosed worldwide (the estimated number of people is 0.5 million cases per year), HCC continue to pose challenging clinical problems. The assessment of the tumor and treatment options needs a multi-disciplinary approach in which the surgeon plays a central role. The aim of this thesis is to update on the incidence, etiology, diagnostic and treatment modalities in patients with HCC.

, ,
Erasmus University Rotterdam
The production of this thesis was financially supported by Bayer Health Care and Astra-Zeneca, Sanfi Synthelabo, Johnston & Johnston Medical, Codman, Covedien, Novartis Oncology, Roche Nederland B.V., Braun Medical B.V., Glaxo SmithKline Oncology
Erasmus MC: University Medical Center Rotterdam

Verhoef, C. (2008, February 13). Clinical Aspects of Hepatocellular Carcinoma. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/15917